Correlation Between Protagonist Therapeutics and Atreca
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Atreca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Atreca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Atreca Inc, you can compare the effects of market volatilities on Protagonist Therapeutics and Atreca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Atreca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Atreca.
Diversification Opportunities for Protagonist Therapeutics and Atreca
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Protagonist and Atreca is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Atreca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atreca Inc and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Atreca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atreca Inc has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Atreca go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Atreca
If you would invest (100.00) in Atreca Inc on November 8, 2024 and sell it today you would earn a total of 100.00 from holding Atreca Inc or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Atreca Inc
Performance |
| Timeline |
| Protagonist Therapeutics |
| Atreca Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Protagonist Therapeutics and Atreca Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Atreca
The main advantage of trading using opposite Protagonist Therapeutics and Atreca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Atreca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will offset losses from the drop in Atreca's long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |